Influence of metabolism on endocrine activities of bisphenol S

Chemosphere

Volumn 157, Issue , 2016, Pages 152-159

  Skledar, Darja Gramec ^a   Schmidt, Jan ^b   Fic, Anja ^a   Klopčič, Ivana ^a   Trontelj, Jurij ^a   Dolenc, Marija Sollner ^a   Finel, Moshe ^c   Mašič, Lucija Peterlin ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bisphenol S; Estrogenic effects; Glucuronidation; Oxidative metabolism; Thyroid hormone receptor

Indexed keywords

CELL CULTURE; CONSUMER PRODUCTS; DETOXIFICATION; ENDOCRINOLOGY; HORMONES; HYDROXYLATION; METABOLITES; PHENOLS;

BISPHENOL S; ESTROGENIC EFFECT; GLUCURONIDATION; OXIDATIVE METABOLISM; THYROID HORMONE RECEPTOR;

METABOLISM;

BISPHENOL S; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; ESTROGEN RECEPTOR; GLUCURONIDE; GLUTATHIONE; PHENOL DERIVATIVE; THYROID HORMONE; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; BIS(4-HYDROXYPHENYL)SULFONE; CYP2C9 PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; ENDOCRINE DISRUPTOR; SULFONE;

BENZENE; BIOTRANSFORMATION; CATALYSIS; CELLS AND CELL COMPONENTS; CYTOCHROME; DETOXIFICATION; ENZYME ACTIVITY; HORMONE; METABOLISM; METABOLITE; ORGANIC COMPOUND;

AEROBIC METABOLISM; ARTICLE; BIOTRANSFORMATION; EC50; ENDOCRINE FUNCTION; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GLUCURONIDATION; HUMAN; HYDROXYLATION; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; METABOLITE; NONHUMAN; REPORTER GENE; SACCHAROMYCES CEREVISIAE; SYNTHESIS; TANDEM MASS SPECTROMETRY; YEAST CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; DRUG INACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM;

ANIMALS; BIOTRANSFORMATION; CELL LINE; CYTOCHROME P-450 CYP2C9; CYTOCHROME P-450 CYP3A; ENDOCRINE DISRUPTORS; GLUCURONIDES; HUMANS; HYDROXYLATION; INACTIVATION, METABOLIC; MICROSOMES, LIVER; PHENOLS; RECEPTORS, ESTROGEN; RECEPTORS, THYROID HORMONE; SACCHAROMYCES CEREVISIAE; SULFONES;

EID: 84969257846     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2016.05.027     Document Type: Article

References (35)

1. Anzenbacher P., Anzenbacherová E. Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 2001, 58(5-6):737-747.
2. Atkinson A., Roy D. In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s). Biochem. Biophys. Res. Commun. 1995, 210(2):424-433.
3. Chen M.Y., Ike M., Fujita M. Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ. Toxicol. 2002, 17(1):80-86.
4. Castro B., Sánchez P., Torres J.M., Ortega E. Bisphenol A, bisphenol F and bisphenol S affect differently 5α-reductase expression and dopamine-serotonin systems in the prefrontal cortex of juvenile female rats. Environ. Res. 2015, 142:281-287.
5. Court M.H., Zhang X., Ding X., Yee K.K., Hesse L.M., Finel M. Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 2012, 42(3):266-277.
6. Eladak S., Grisin T., Moison D., Guerquin M.J., N'Tumba-Byn T., Pozzi-Gaudin S., Benachi A., Livera G., Rouiller-Fabre V., Habert R. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil. Steril. 2015, 103(1):11-21.
7. Fic A., Zegura B., Gramec D., Peterlin Mašič L. Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay. Chemosphere 2014, 112:362-369.
8. Fisher M.B., Campanale K., Ackermann B.L., VandenBranden M., Wrighton S.A. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab. Dispos. 2000, 28(5):560-566.
9. Freitas J., Cano P., Craig-Veit C., Goodson M.L., Furlow J.D., Murk A.J. Detection of thyroid hormone receptor disruptors by a novel stable in vitro reporter gene assay. Toxicol. In Vitro 2011, 25(1):257-266.
10. Gramec Skledar D., Troberg J., Lavdas J., Peterlin Mašič L., Finel M. Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10. Xenobiotica 2015, 45(6):511-519.
11. Grignard E., Lapenna S., Bremer S. Weak estrogenic transcriptional activities of Bisphenol A and Bisphenol S. Toxicol. In Vitro 2012, 26(5):727-731.
12. Hashimoto Y., Nakamura M. Estrogenic activity of dental materials and bisphenol-A related chemicals in vitro. Dent. Mater. J. 2000, 19(3):245-262.
13. Héliès-Toussaint C., Peyre L., Costanzo C., Chagnon M.C., Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? an in vitro study. Toxicol. Appl. Pharmacol. 2014, 280(2):224-235.
14. Kitamura S., Suzuki T., Sanoh S., Kohta R., Jinno N., Sugihara K., Yoshihara S., Fujimoto N., Watanabe H., Ohta S. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol. Sci. 2005, 84(2):249-259.
15. Kuruto-Niwa R., Nozawa R., Miyakoshi T., Shiozawa T., Terao Y. Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ. Toxicol. Pharmacol. 2005, 19(1):121-130.
16. Li M., Yang Y., Yin J., Zhang J., Feng Y., Shao B. Biotransformation of Bisphenol AF to its major glucuronide metabolite reduces estrogenic activity. PLoS One 2013, 8(12):e83170.
17. Liao C., Kannan K. A survey of bisphenol A and other bisphenol analogues in foodstuffs from nine cities in China. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk. Assess. 2014, 31(2):319-329.
18. Liao C., Liu F., Alomirah H., Loi V.D., Mohd M.A., Moon H.B., Nakata H., Kannan K. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ. Sci. Technol. 2012, 46(12):6860-6866.
19. Liao C., Liu F., Guo Y., Moon H.B., Nakata H., Wu Q., Kannan K. Occurrence of eight bisphenol analogues in indoor dust from the United States and several Asian countries: implications for human exposure. Environ. Sci. Technol. 2012, 46(16):9138-9145.
20. Liao C., Liu F., Kannan K. Bisphenol S, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol a residues. Environ. Sci. Technol. 2012, 46(12):6515-6522.
21. Lotti N., Collona M., Fiorini M., Finelli L., Berti C. Poly(butylene terephthalate) modified with ethoxylated bisphenol S with increased glass transition temperature and improved thermal stability. Polymer 2011, 52(4):901-911.
22. Moriyama K., Tagami T., Akamizu T., Usui T., Saijo M., Kanamoto N., Hataya Y., Shimatsu A., Kuzuya H., Nakao K. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 2002, 87(11):5185-5190.
23. Nakamura S., Tezuka Y., Ushiyama A., Kawashima C., Kitagawara Y., Takahashi K., Ohta S., Mashino T. Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity. Toxicol. Lett. 2011, 203(1):92-95.
24. Niwa T., Fujimoto M., Kishimoto K., Yabusaki Y., Ishibashi F., Katagiri M. Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17. Biol. Pharm. Bull. 2001, 24(9):1064-1067.
25. Peterson L.A., Cummings M.E., Vu C.C., Matter B.A. Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial. Drug Metab. Dispos. 2005, 33(10):1453-1458.
26. Ritter J.K. Intestinal UGTs as potential modifiers of pharmacokinetics and biological responses to drugs and xenobiotics. Expert Opin. Drug Metab. Toxicol. 2007, 3(1):93-107.
27. Rochester J.R., Bolden A.L. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ. Health Perspect. 2015, 123(7):643-650.
28. Sato Y., Nagata M., Tetsuka K., Tamura K., Miyashita A., Kawamura A., Usui T. Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 2014, 42(5):885-889.
29. Schmidt J., Kotnik P., Trontelj J., Knez Ž., Peterlin Mašič L. Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes. Toxicol. In Vitro 2013, 27(4):1267-1276.
30. Schmidt J., Peterlin Mašič L. Organic synthetic environmental endocrine disruptors: structural classes and metabolic fate. Acta Chim. Slov. 2012, 59(4):722-738.
31. Sirbasku D.A., Pakala R., Sato H., Eby J.E. Thyroid hormone dependent pituitary tumor cell growth in serum-free chemically defined culture. A new regulatory role for apotransferrin. Biochemistry 1991, 30(30):7466-7477.
32. Viñas R., Watson C.S. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ. Health Perspect. 2013, 121(3):352-358.
33. Yoshihara S., Mizutare T., Makishima M., Suzuki N., Fujimoto N., Igarashi K., Ohta S. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol. Sci. 2004, 78(1):50-59.
34. Yu X., Xue J., Yao H., Wu Q., Venkatesan A.K., Halden R.U., Kannan K. Occurrence and estrogenic potency of eight bisphenol analogs in sewage sludge from the U.S. EPA targeted national sewage sludge survey. J. Hazard. Mater 2015, 299:733-739.
35. Zhou X., Kramer J.P., Calafat A.M., Ye X. Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 2013, 944:152-156.